Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1387, Issue 1-2, 1998, Pages 184-194

  Mauray, Sandrine ^a   De Raucourt, Emmanuelle ^a   Talbot, Jean Claude ^b   Dachary Prigent, Jeanne ^c   Jozefowicz, Marcel ^d   Fischer, Anne Marie ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CNRS   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d UNIVERSITÉ PARIS 13   (France)

Author keywords

Anticoagulant; Factor IXa; Fucoidan; Low molecular weight heparin

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 9A; DALTEPARIN; ENOXAPARIN; FUCOIDIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; POLYSACCHARIDE; PROTEINASE; SERINE PROTEINASE; THROMBIN;

ANISOTROPY; ANTICOAGULATION; ARTICLE; BINDING AFFINITY; CHEMICAL REACTION KINETICS; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENZYME INHIBITION; KINETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANTICOAGULANTS; ANTITHROMBINS; DALTEPARIN; ENOXAPARIN; ENZYME INHIBITORS; FACTOR IXA; FLUORESCEINS; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; HEPARIN; HUMANS; KINETICS; NADROPARIN; POLYSACCHARIDES; PROTEIN BINDING;

EID: 0032497417     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(98)00120-4     Document Type: Article

References (38)

1. Rosenberg R.D., Damus P.S. Purification and mechanism of action of human thrombin-heparin cofactor. J. Biol. Chem. 18:1973;6490-6505.
2. I. Björk, S.T. Olson, J.D. Shore, in D.A. Lane, U. Lindahl (Eds.), Heparin, Chemical and Biological Properties, Clinical Applications, CRC Press Inc., Boca Raton, FL, 1989, pp. 1-23.
3. Bourin M.C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 289:1993;313-330.
4. Lawson J.H., Butenas S., Ribarik N., Mann K.G. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J. Biol. Chem. 268:1993;767-770.
5. Choay J., Petitou M., Lormeau J.C., Sinaÿ P., Casu B., Gatti G. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Commun. 116:1983;492-499.
6. Gettins P., Patston P.A., Schapira M. The role of conformational change in serpin structure and function. BioEssays. 15:1993;461-467.
7. Tollefsen D.M., Marjerus D.W., Blank M.K. Heparin cofactor II. J. Biol. Chem. 252:1982;2162-2169.
8. Springer G.F., Wurzel H.A., McNeal G.M. Jr., Ansell N.J., Doughty M.F. Isolation of anticoagulant fractions from crude fucoidin. Proc. Soc. Exp. Biol. Med. 94:1957;404-409.
9. Boisson-Vidal C., Colliec-Jouault S., Fischer A.M., Tapon-Bretaudière J., Sternberg C., Durand P., Jozefonvicz J. Biological activities of fucans extracted from brown seaweeds. Drugs Future. 16:1991;539-545.
10. Mauray S., Sternberg C., Theveniaux J., Millet J., Sinquin C., Tapon-Bretaudière J., Fischer A.M. Venous antithrombotic and anticoagulant activities of a fucoidan fraction. Thromb. Haemost. 74:1995;1280-1285.
11. Kloareg B., Quatrano R.S. Structure of the cell walls of marine algae and ecophysiological functions of the matrix polysaccharides. Oceanogr. Mar. Biol. Annu. Rev. 26:1988;259-315.
12. Patankar M.S., Oehninger S., Barnett T., Williams R.L., Clark G.F. A revised structure for fucoidan may explain some of its biological activities. J. Biol. Chem. 268:1993;21770-21776.
13. Grauffel V., Kloareg B., Mabeau S., Durand P., Jozefonvicz J. New natural polysaccharides with potent antithrombic activity: fucans from brown algae. Biomaterials. 10:1989;363-368.
14. Nishino T., Aizu Y., Nagumo T. The influence of sulfate content and molecular weight of a fucan sulfate from the brown seaweed Ecklonia kurome on its antithrombin activity. Thromb. Res. 64:1991;723-731.
15. Church F.C., Meade J.B., Treanor R.E., Whinna H.C. Antithrombin activity of fucoidan. J. Biol. Chem. 264:1989;3618-3623.
16. Nishino T., Aizu Y., Nagumo T. Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome. Thromb. Res. 62:1991;765-773.
17. Colliec S., Fischer A.M., Tapon-Bretaudière J., Boisson C., Durand P., Jozefonvicz J. Anticoagulant properties of a fucoidan fraction. Thromb. Res. 64:1991;143-154.
18. Mauray S., de Raucourt E., Chaubet F., Maïga-Revel O., Sternberg C., Fischer A.M. Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction. J. Biomater. Sci. Polymer Edn. 9:1998;373-387.
19. Rosenberg J.S., McKenna P.W., Rosenberg R.D. Inhibition of human factor IXa by human antithrombin. J. Biol. Chem. 250:1975;8883-8888.
20. Pieters J., Willems G., Hemker H.C., Lindhout T. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation. J. Biol. Chem. 263:1988;15313-15318.
21. Pieters J., Lindhout T., Willems G. Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma. Blood. 76:1990;549-554.
22. Colliec S., Boisson-Vidal C., Jozefonvicz J. A low molecular weight fucoidan fraction form the brown seaweed Pelvetia canaliculata. Phytochemistry. 35:1994;697-700.
23. Blakeslee D., Baines M.G. Immunofluorescence using dichloro triazinylaminofluorescein (DTAF); preparation and fractionation of labelled IgG. J. Immunol. Methods. 13:1976;305-320.
24. Letourneur D., Caleb B.L., Castellot J.J. Heparin binding, internalization and metabolism in vascular smooth muscle cells: 1. Upregulation of heparin binding correlates with antiproliferative activity. J. Cell. Physiol. 165:1995;676-686.
25. Van Dieijen G., Tas G., Rosing J., Hemker H.C. The related of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256:1981;3433-3442.
26. Van Dieijen G., van Rijn J.L.M.L., Govers-Riemslag J.W.P., Hemker H.C., Rosing J. Assembly of the intrinsic factor X activating complex - Interactions between factor IXa, factor VIIIa and phospholipid. Thromb. Haemost. 53:1985;396-400.
27. Soons H., Janssen-Claessen T., Hemker H.C., Tans G. The effect of platelets in the activation of human blood coagulation factor IX by factor XIa. Blood. 68:1986;140-148.
28. Jordan R., Beeler D., Rosenberg R. Fractionation of low molecular weight heparin species and their interaction with antithrombin. J. Biol. Chem. 254:1979;2902-2913.
29. Maaroufi R.M., Jozefonvicz M., Tapon-Bretaudière J., Jozefonvicz J., Fischer A.M. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulfates, native or oversulfated, and an heparin-like dextran derivative. Biomaterials. 18:1997;359-366.
30. J.R. Lakowicz, Principles of fluorescence spectroscopy, Plenum Press, New York, 1983.
31. W.H. Press, B.P. Flannery, S.A. Teukolsky, W.T. Vetterling, Numerical Recipes in C, Cambridge University Press, pp. 517-565, 1988.
32. Jordan R.E., Oosta G.M., Gardner W.T., Rosenberg R.D. The binding of low molecular weight heparin to hemostatic enzymes. J. Biol. Chem. 255:1980;10073-10080.
33. Jordan R.E., Oosta G.M., Gardner W.T., Rosenberg R.D. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. J. Biol. Chem. 255:1980;10081-10090.
34. Barrowcliffe T.W., Thomas D.P. Anticoagulant activities of heparin and fragments. Ann. NY Acad. Sci. 556:1989;132-145.
35. Sinniger V., Tapon-Bretaudière J., Millien C., Muller D., Jozefonvicz J., Fischer A.M. Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A-Sepharose. J. Chromatogr. 615:1993;215-223.
36. Lensing A.W.A., Prins M.H., Davidson B.L., Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. Arch. Intern. Med. 155:1995;601-607.
37. Weitz J.I. Low-molecular-weight heparins. New Engl. J. Med. 337:1997;688-698.
38. Barrowcliffe T.W. Low molecular weight heparin(s). Br. J. Haematol. 90:1995;1-7.